Page last updated: 2024-08-23

meglitinide and Carcinoma 256, Walker

meglitinide has been researched along with Carcinoma 256, Walker in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Enzmann, F; Gastpar, H; Weissgerber, PW; Zoltobrocki, M	1

Other Studies

1 other study(ies) available for meglitinide and Carcinoma 256, Walker

Article	Year
The inhibition of cancer cell stickiness, a model for investigation of platelet aggregation inhibitors in vivo. Effect of the sulfonyl urea derivatives, glibenclamide, gliclazide, and HB180, as well as the carboxylic acid derivative, meglitinide. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1982, Volume: 180, Issue:1 Topics: Animals; Benzamides; Carcinoma 256, Walker; Cell Aggregation; Diabetes Mellitus; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Platelet Aggregation; Platelet Count; Rats; Rats, Inbred Strains; Sulfonylurea Compounds	1982

Article

Year

The inhibition of cancer cell stickiness, a model for investigation of platelet aggregation inhibitors in vivo. Effect of the sulfonyl urea derivatives, glibenclamide, gliclazide, and HB180, as well as the carboxylic acid derivative, meglitinide.

Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1982, Volume: 180, Issue:1

Topics: Animals; Benzamides; Carcinoma 256, Walker; Cell Aggregation; Diabetes Mellitus; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Platelet Aggregation; Platelet Count; Rats; Rats, Inbred Strains; Sulfonylurea Compounds

1982